Adjuvant therapy in node positive pre/perimenopausal breast cancer patients: CMF 3 vs. 6 with or without reintroduction of chemotherapy.

Study Chair
Prof. Monica Castiglione - Bern, Switzerland

Statistician
Karen Price

Lead Trial Coordinator
Holly Shaw

Director of Data Management
Lynette Blacher

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 833 3990
Fax: +1 716 836 6097
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Date of Activation
July 1986

Date of Closure
April 30, 1993

Final Accrual
1475 patients

Date of Discontinued Follow-up
January 31, 2008

International Breast
Cancer Study Group

Effingerstrasse 40
3008 Bern, Switzerland

Contact
Phone: +41 31 511 94 00
E-mail: ibcsgcc@ibcsg.org

Member Login